Literature DB >> 9207239

L-type Ca2+ channel-insulin-like growth factor-1 receptor signaling impairment in aging rat skeletal muscle.

M Renganathan1, W E Sonntag, O Delbono.   

Abstract

The present study investigates the modulation of skeletal muscle L-type Ca2+ channel receptor in response to insulin-like growth factor-1 receptor (IGF-1R) activation. Single extensor digitorum longus and multifiber preparations were isolated from 7- (young), 14- (middle-age) and 28-(old) month- Fisher 344 X Brown Norway rats. Calcium current was potentiated in fibers from young and middle-age rats due to a -13 mV shift in half-activation potential. Fibers from old animals failed to show current potentiation in response to IGF-1R activation. IGF-1 induced a ten-fold increase in the phosphorylation of the L-type Ca2+ channel alpha1 subunit in young and middle-age fibers but failed to induce phosphorylation in old fibers. Addition of 0.5 mM Ca2+ increased the IGF-1 induced phosphorylation in young and middle-age fibers three fold but not in old fibers. The tyrosine kinase inhibitor, genistein, and the PKC inhibitor peptide, 19-36, decreased IGF-1 induced phosphorylation of alpha1 subunit to 15% in young and middle-age fibers but failed to inhibit phosphorylation in old fibers. These results demonstrate that the IGF-1-L-type Ca2+ channel alpha1 subunit signaling is impaired in skeletal muscle fibers from old animals due to alterations in the trk-PKC pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207239     DOI: 10.1006/bbrc.1997.6881

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Impaired bladder function in aging male rats.

Authors:  Weixin Zhao; Tamer Aboushwareb; Chanda Turner; Cathy Mathis; Colleen Bennett; William E Sonntag; Karl-Erik Andersson; George Christ
Journal:  J Urol       Date:  2010-05-20       Impact factor: 7.450

Review 2.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 3.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

Review 4.  The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing.

Authors:  W E Sonntag; C Lynch; P Thornton; A Khan; S Bennett; R Ingram
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

5.  Insulin-like growth factor-1 enhances rat skeletal muscle charge movement and L-type Ca2+ channel gene expression.

Authors:  Z M Wang; M L Messi; M Renganathan; O Delbono
Journal:  J Physiol       Date:  1999-04-15       Impact factor: 5.182

6.  Sustained overexpression of IGF-1 prevents age-dependent decrease in charge movement and intracellular Ca(2+) in mouse skeletal muscle.

Authors:  Zhong-Min Wang; María Laura Messi; Osvaldo Delbono
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

7.  Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor.

Authors:  Sabata Pierno; Annamaria De Luca; Jean-François Desaphy; Bodvael Fraysse; Antonella Liantonio; Maria Paola Didonna; Marcello Lograno; Daniela Cocchi; Roy G Smith; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Ca(2+) calmodulin kinase and calcineurin mediate IGF-1-induced skeletal muscle dihydropyridine receptor alpha(1S) transcription.

Authors:  Z Zheng; Z M Wang; O Delbono
Journal:  J Membr Biol       Date:  2004-01-15       Impact factor: 1.843

Review 9.  The emerging role of the sympathetic nervous system in skeletal muscle motor innervation and sarcopenia.

Authors:  Osvaldo Delbono; Anna Carolina Zaia Rodrigues; Henry Jacob Bonilla; Maria Laura Messi
Journal:  Ageing Res Rev       Date:  2021-02-18       Impact factor: 10.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.